Castleview Partners’s Incyte INCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-168
Closed -$11.7K 360
2024
Q4
$11.7K Buy
168
+10
+6% +$713 0.01% 561
2024
Q3
$10.4K Buy
158
+48
+44% +$3.06K 0.01% 538
2024
Q2
$6.67K Buy
110
+43
+64% +$2.44K ﹤0.01% 586
2024
Q1
$3.82K Buy
67
+27
+68% +$1.62K ﹤0.01% 673
2023
Q4
$2.51K Buy
+40
New +$2.26K ﹤0.01% 685

Other funds holding INCY

Castleview Partners's INCY Position: Q1 2025 in Review

Castleview Partners sold out of Incyte (INCY) in Q1 2025, closing a stake of 168 shares — an estimated $11.7K sold.

Castleview Partners first reported a position in INCY in Q4 2023 and held it in 5 quarters. The position peaked at $11.7K in Q4 2024. 629 funds tracked by Wall St. Rank hold INCY as of Q1 2025.

  • Castleview Partners reported no remaining Incyte position as of Q1 2025 after selling out during the quarter.
  • Castleview Partners sold 168 Incyte shares in Q1 2025, an estimated $11.7K.
  • Castleview Partners first reported a position in Incyte in Q4 2023 and held it in 5 quarters.
  • Castleview Partners's Incyte position peaked at $11.7K in Q4 2024.
  • 629 funds tracked by Wall St. Rank held Incyte as of Q1 2025.

Based on Castleview Partners's 13F filing for Q1 2025, filed 22 Apr 2025.